- Czech patient with lung adenocarcinoma with the BRAF V600E mutation succesfully treated with dabrafenib plus trametinib2021 | Central Library of Charles University, Faculty of Medicine in Pilsen
- BRAF(V600E)mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic2010 | First Faculty of Medicine
- Rychlý nástup a dlouhé trvání kompletní remise u pacienta s BRAF V600 pozitivním metastazujícím melanomem léčeným vemurafenibem2016 | First Faculty of Medicine
- Safety and efficacy of vemurafenib in BRAF V600E and BRAF V600K mutatuion positive melanoma(BRIM-3): extended follow up of phase 3 randimised open label study2014 | Publication without faculty affiliation
- Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition2020 | Second Faculty of Medicine
- BRAF V600E mutant oligodendroglioma-like tumors with chromosomal instability in adolescents and young adults2020 | Central Library of Charles University
- Different effects of the inhibition of Src activity on Akt/PKB in melanoma cells with wild BRAF and mutated BRAF V600E2013 | First Faculty of Medicine
- Atypická velmi pomalá regrese metastáz melanomu při léčbě vemurafenibem2016 | First Faculty of Medicine
- Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas2017 | Central Library of Charles University, Second Faculty of Medicine
- Nonhealing atopic eczema2017 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Current perspectives on the treatment of BRAF mutated colorectal carcinoma2020 | Publication without faculty affiliation
- Long-term survival on vemurafenib monotherapy2017 | Publication without faculty affiliation
- MicroRNA Deregulation in Papillary Thyroid Cancer and its Relationship With BRAF V600E Mutation2021 | Publication without faculty affiliation
- BRAF(V600E) mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic2010 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Dlouhodobé přežívání pacientky s metastazujícím melanomem při monoterapii vemurafenibem2016 | First Faculty of Medicine
- Mechanisms of resistance in malignant melanoma treated by targeted therapy2020 | First Faculty of Medicine
- Pokračování v léčbě vemurafenibem i po progresi onemocnění2016 | Publication without faculty affiliation
- BRAF(V600E) mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic2010 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- BRAF(V600E) mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic2010 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Correlation among the BRAF Gene Mutation Status, Clinicopathological Features of Primary Tumour, and Lymph Node Metastasizing of Papillary Thyroid Carcinoma2014 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Targeted therapy in metastatic melanoma2014 | Publication without faculty affiliation
- Advances in the treatment of metastatic melanoma2013 | Publication without faculty affiliation
- Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process Clinicopathologic and Molecular Study of 7 Cases2020 | Faculty of Medicine in Pilsen
- Controversial impact of mutational analysis on thyroid fine-needle aspiration biopsies - pilot Study2018 | Faculty of Medicine in Hradec Králové
- Metastatic melanoma - when and how it should by treated2016 | Publication without faculty affiliation
- Dabrafenib in the treatment of metastatic melanoma2014 | Publication without faculty affiliation
- The Year 2011 is the Year of Melanoma: Melanoma Forum, Frankfurt, 19. May 20112011 | Faculty of Medicine in Hradec Králové
- Case report of a patient with metastatic melanoma treated with several lines of systemic treatment2021 | First Faculty of Medicine
- Anti-EGFR treatment of colorectal cancer2021 | Publication without faculty affiliation
- Dabrafenib: využití v léčbě BRAF pozitivních metastazujících melanomů2014 | Publication without faculty affiliation